Advertisement
News
Subscribe to MDT Magazine News

Okla. death row inmates protest new execution drug

November 19, 2010 8:45 am | by SEAN MURPHY - Associated Press - Associated Press | Comments

Two death row inmates in Oklahoma asked a federal judge on Friday to stop their pending executions after the state said it planned to substitute the anesthetic used during lethal injections because of a drug shortage.Oklahoma is one of several states that have been scrambling after the sole...

Propoxyphene: Withdrawal - Risk of Cardiac Toxicity(2)

November 19, 2010 8:31 am | by U.S. Food & Drug Administration | Comments

New data shows that Propoxyphene and Propoxyphene-containing products can cause serious toxicity to the heart, even when used at therapeutic doses.

TOPICS:

Propoxyphene: Withdrawal - Risk of Cardiac Toxicity

November 19, 2010 8:30 am | Comments

New data shows that Propoxyphene and Propoxyphene-containing products can cause serious toxicity to the heart, even when used at therapeutic doses.

Advertisement

ECRI Institute PSO Chosen by Tennessee Hospital Association for Patient Safety Services

November 19, 2010 7:35 am | by Bio-Medicine.Org | Comments

PLYMOUTH MEETING, Pa., Nov. 19, 2010 /PRNewswire-USNewswire/ -- ECRI Institute Patient Safety Organization (PSO) today announces an agreement to provide patient safety services to the Tennessee Center for Patient Safety established by the Tennessee Hospital Association. ECRI Institute PSO...

TOPICS:

Boston Scientific to Acquire Sadra Medical

November 19, 2010 7:34 am | by Boston Scientific | Comments

Innovative percutaneous aortic valve replacement system provides entry into emerging market of structural heart disease

TOPICS:

Xanodyne Agrees to Withdraw Propoxyphene From the U.S. Market

November 19, 2010 7:34 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Nov. 19, 2010 /PRNewswire-USNewswire/ -- Xanodyne Pharmaceuticals Inc., which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food...

TOPICS:

FDA Approves Xgeva to Help Prevent Cancer-Related Bone Injury

November 19, 2010 7:34 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Nov. 19, 2010 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events...

TOPICS:

Solos Endoscopy, Inc. Announces Recapitalization Plan for 2011

November 19, 2010 7:33 am | by Bio-Medicine.Org | Comments

BOSTON, Nov. 19, 2010 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company's management has approved its 2011 recapitalization plan in order to position itself for growth over the next twelve months. The recapitalization plan is designed to increase...

TOPICS:
Advertisement

Report Examines Trends in Global Manufacturing, Goods Movement and Consumption and Their Effect on the Growth of United States Ports and Distribution

November 19, 2010 6:40 am | by Material Handling Industry of America | Comments

Global shifts in manufacturing, consumption trends and international competition are three leading factors that will shape the future of goods movement and the demand for warehouse and distribution space, according to a report issued by The NAIOP Research

St. Jude Medical buys AGA for $1.04 billion

November 19, 2010 5:45 am | by The Associated Press | Comments

St. Jude Medical Inc. says it has completed its $1.04 billion buyout of rival heart device maker AGA Medical Holdings Inc.St. Jude Medical said late Thursday that about 91.1 percent of AGA Medical Holdings Inc.'s outstanding shares had been tendered by the Wednesday deadline as part the buyout....

NIH Awards $10 Million to Develop Microneedle Vaccine Patch

November 19, 2010 5:38 am | by Georgia Tech Institute of Technology | Comments

The National Institutes of Health (NIH) has awarded $10 million to advance a technology for the painless, self-administration of flu vaccine using patches containing tiny microneedles that dissolve into the skin.

Lynch Syndrome Teleconference

November 19, 2010 5:36 am | by AACR | Comments

PHILADELPHIA — Widespread genetic testing for Lynch Syndrome appears to be a cost-effective strategy for identifying those at risk for colorectal and endometrial cancer, according to a report in Cancer Prevention Research, a journal of the American Association for Cancer Research. The...

TOPICS:

CDRH Learn (New Courses Available in English, Spanish, and Chinese)

November 19, 2010 5:31 am | by U.S. Food & Drug Administration | Comments

CDRH Learn is our latest innovative educational tool. It consists of a series of training modules describing many aspects of medical device and radiological health regulation, covering both premarket and postmarket issues...

TOPICS:

Calif health insurers poor at customer service

November 19, 2010 4:45 am | by The Associated Press | Comments

A California Department of Insurance survey shows most health insurers do a poor job of paying claims and providing customer service to preferred provider organization members.The new quality report card gives low customer service ratings to Anthem Blue Cross, Blue Shield of California, Health...

IPC The Hospitalist Co. buys Michigan practice

November 19, 2010 4:45 am | by The Associated Press | Comments

IPC The Hospitalist Company Inc. said Friday it bought Hospitalists of West Michigan PC in Grand Rapids, Mich.Terms of the deal were not disclosed.IPC, a North Hollywood, Calif., physician group practice company, said the deal expands its presence in a Michigan market where it is already...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading